Arthur Allen | (TNS) KFF Health News When doctors began using the drug sotorasib in 2021 with high expectations for its innovative approach to attacking lung cancer, retired medical technician Don Crosslin was an early beneficiary. Crosslin started the drug that July. His tumors shrank, then stabilized. But while the drug has helped keep him alive, its side effects have gradually narrowed the confines of his life, said Crosslin, 76, who lives in Ocala, Florida: “My appetite has been minimal.
Amgen Plows Ahead With Costly, Highly Toxic Cancer Dosing Despite Fda Challenge
Tribune News Service, South Florida Sun-Sentinel
Fri, 05/10/2024 - 11:46am
Topics: arthur allen tns kff health don crosslin ocala florida july but i lumakras crosslin s richard pazdur new england journal medicine november elissa snook united states there s mark ratain chicago deciding dosage under project optimus lauren-jei mccarthy when julie gralow american society clinical oncology julie bullock donald harvey emory university american medical association sotorasib kras g12c california-san francisco kevan shokat figured they yale university grant gi the fda noted patients jill feldman kaiser permanente stephen shivinsky smaller doses and revenue fda mccarthy switching social security ratain a amgen s handling medicare medicaid services cms fda-approved aaron smith drug although j&j zytiga national comprehensive cancer network post-marketing emory s harvey it s kff health tribune content agency llc he a kff health kff health news i in crosslin fda project optimus amgen fda s the fda the ratain ratain university that s that harvey johnson company effects lung approval month spokesperson development label change patent study year costs showed conduct effort tumors shrank stomach process day tolerable mouth early accelerated brand roughly phase sores spend target longer effect quarter advanced professor docetaxel excess approach begun lot pay months
BING NEWS:
- Daily marijuana use exceeds daily drinking in US
Millions of people in the U.S. report using marijuana daily or nearly every day, according to an analysis of national survey data, and those people now outnumber those who say they are daily or nearly ...
05/22/2024 - 5:44 am | View Link - US FDA approves Amgen drug for small cell lung cancer
Amgen said it will need to complete its larger, pivotal trial in advanced small cell lung cancer to receive full FDA approval of the drug. The company is also testing tarlatamab for treating ...
05/17/2024 - 6:55 am | View Link - US FDA Approves Amgen Drug for Small Cell Lung Cancer
US FDA Approves Amgen Drug for Small Cell Lung Cancer (Reuters) -The U.S. Food and Drug Administration on Thursday granted accelerated approval to Amgen's tarlatamab, a targeted immunotherapy for ...
05/16/2024 - 4:22 am | View Link - F.D.A. Approves Drug for Persistently Deadly Form of Lung Cancer
The treatment is for patients with small cell lung cancer, which afflicts about 35,000 people in the U.S. a year. By Gina Kolata The Food and Drug Administration on Thursday approved an innovative ...
05/15/2024 - 1:00 pm | View Link - Amgen plows ahead with costly, highly toxic cancer dosing despite FDA challenge
High doses become routine patient care even when they make patients so ill that they skip doses or stop taking the drugs. “There’s a gap in FDA’s authority that results in patients getting excess ...
05/9/2024 - 11:31 pm | View Link - More
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more